We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7751:TSECanon Inc. Analysis

Data as of 2026-06-12 - not real-time

¥4,273.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Canon Inc. (7751.T) trades at ¥4,273, just below its 20‑day SMA of ¥4,275.4 and modestly under its 50‑day SMA of ¥4,291.6, indicating a short‑term price compression near key moving averages. Technical signals are mixed: the MACD histogram is positive (≈¥3.33) and the MACD line sits above the signal line, suggesting bullish momentum, yet the broader trend remains bearish and volume is decreasing, with the price hovering between the identified support at ¥4,116 and resistance at ¥4,447. Fundamentally, Canon appears attractively priced – its trailing P/E of 11.6 is far below the industry average of 36.8, and the dividend yield of 3.74% with a 43.6% payout ratio is supported by strong operating cash flow (¥428 bn) and free cash flow (¥68.8 bn). The DCF‑derived fair value of ¥525 is dramatically lower than the market price, creating a tension between absolute and relative valuation, but the upside/downside estimate of +12.3% suggests modest upside potential. Recent product news, such as the EOS R6 V launch, could provide a short‑term catalyst for the imaging segment, while the diversified portfolio across printing, medical, and industrial equipment underpins longer‑term stability. With a low beta of 0.14, 30‑day volatility of 20%, and a solid balance sheet (debt‑to‑equity 33.7%), Canon presents a balanced risk‑return profile suitable for value‑oriented investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram despite bearish trend
  • Price near key support level
  • Decreasing volume indicating potential consolidation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Low P/E relative to industry peers
  • Attractive dividend yield with sustainable payout
  • Upside potential of ~12% based on valuation model

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified business segments reducing cyclical exposure
  • Strong cash generation and modest leverage
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin6.61%
P/E Ratio11.6
ROE9.37%
ROA4.54%
Debt/Equity33.70
P/B Ratio1.1
Op. Cash Flow¥428.5B
Free Cash Flow¥68.8B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI48.8
Support¥4,116.00
Resistance¥4,447.00
MA 20¥4,275.40
MA 50¥4,291.60
MA 200¥4,476.03
MACDBullish
VolumeDecreasing
Fear & Greed Index88.68

Valuation

Fair Value¥524.83
Target Price¥4,800.00
Upside/Downside12.33%
GradeFair
TypeValue
Dividend Yield3.74%

Risk Assessment

Beta0.14
Volatility20.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.